Premium
Sionna Therapeutics Inc (SION)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | OrbiMed Advisors LLCSociété | -115,84k | 5,27M | Automatic Disposition | 45,50 | 2,56M | -4,34% |
| 2026-05-27 | OrbiMed Advisors LLCSociété | -101,00 | 4,49k | Automatic Disposition | 44,49 | 2,67M | -0,00% |
| 2026-05-07 | OrbiMed Advisors LLCSociété | -292,95k | 13,36M | Automatic Disposition | 44,58 - 46,22 | 2,67M | -9,88% |
| 2026-04-17 | OrbiMed Advisors LLCSociété | -55,35k | 2,47M | Automatic Disposition | 44,52 - 44,68 | 2,96M | -1,83% |
| 2026-04-17 | OrbiMed Advisors LLCSociété | -52,40k | 2,34M | Vente | 44,68 | 2,97M | -1,73% |
| 2026-04-14 | OrbiMed Advisors LLCSociété | -510,58k | 22,95M | Automatic Disposition | 44,51 - 45,34 | 3,02M | -14,46% |
| 2026-03-05 | Ms. Jennifer FitzpatrickChief Legal Officer | -10,25k | 284,39k | Derivative Exercise and Sale | 6,11 - 33,86 | 0,00 | - |
| 2026-02-02 | OrbiMed Advisors LLCSociété | -30,95k | 1,38M | Vente | 44,57 - 44,58 | 3,53M | -0,87% |
| 2026-01-22 | TPG Capital, L.P.Société | -250,00k | 10,00M | Vente | 40,00 | 6,49M | -3,71% |
| 2025-12-24 | OrbiMed Advisors LLCSociété | -33,36k | 1,49M | Vente | 44,55 | 3,56M | -0,93% |
| 2025-12-17 | OrbiMed Advisors LLCSociété | -1,88k | 83,43k | Vente | 44,49 - 44,50 | 3,60M | -0,05% |
| 2025-12-05 | Ms. Jennifer FitzpatrickChief Legal Officer | -10,25k | 352,70k | Derivative Exercise and Sale | 6,11 - 40,52 | 0,00 | - |
| 2025-11-24 | OrbiMed Advisors LLCSociété | -108,07k | 4,81M | Vente | 44,49 - 44,60 | 3,60M | -2,92% |
| 2025-11-20 | RA Capital Management, L.P.Société | -30,32k | 1,20M | Vente | 39,50 - 40,50 | 9,91M | -0,31% |
| 2025-11-17 | RA Capital Management, L.P.Société | -136,32k | 5,50M | Vente | 39,57 - 42,10 | 9,94M | -1,35% |
| 2025-11-19 | RA Capital Management, L.P.Société | -31,00 | 1,26k | Vente | 40,61 | 9,94M | -0,00% |
| 2025-10-24 | RA Capital Management, L.P.Société | -373,61k | 14,76M | Vente | 39,50 - 39,58 | 10,07M | -3,58% |
| 2025-10-21 | Mr. Michael CloonanPresident, CEO & Director | -99,80k | 3,01M | Derivative Exercise and Sale | 6,11 - 37,31 | 547,34k | - |
| 2025-10-21 | Atlas Venture Advisors, Inc.Société | -4,69k | 153,25k | Vente | 32,69 | 3,00M | -0,16% |
| 2025-10-21 | Atlas Venture Advisors, Inc.Société | -84,19k | 2,89M | Automatic Disposition | 32,69 - 36,42 | 3,00M | -2,73% |
| 2025-10-16 | Atlas Venture Advisors, Inc.Société | -16,07k | 515,09k | Vente | 30,15 - 33,47 | 3,08M | -0,52% |
| 2025-10-16 | Atlas Venture Advisors, Inc.Société | -270,30k | 8,74M | Automatic Disposition | 30,15 - 33,47 | 3,08M | -8,06% |
| 2025-10-15 | Mr. Michael CloonanPresident, CEO & Director | -25,20k | 634,18k | Derivative Exercise and Sale | 6,11 - 34,00 | 547,34k | - |
| 2025-10-10 | Atlas Venture Advisors, Inc.Société | -3,51k | 105,26k | Vente | 29,98 | 3,37M | -0,10% |
| 2025-10-10 | Atlas Venture Advisors, Inc.Société | -191,42k | 5,83M | Automatic Disposition | 29,95 - 31,12 | 3,37M | -5,37% |
| 2025-10-03 | Atlas Venture Advisors, Inc.Société | -6,55k | 196,44k | Vente | 30,00 | 3,57M | -0,18% |
| 2025-10-03 | Atlas Venture Advisors, Inc.Société | -43,00k | 1,29M | Automatic Disposition | 29,95 - 30,00 | 3,57M | -1,19% |
| 2025-09-29 | Atlas Venture Advisors, Inc.Société | -11,47k | 345,07k | Vente | 30,09 | 3,62M | -0,32% |
| 2025-09-29 | Atlas Venture Advisors, Inc.Société | -67,23k | 2,02M | Automatic Disposition | 29,95 - 30,09 | 3,62M | -1,83% |
| 2025-09-26 | Mr. Michael CloonanPresident, CEO & Director | -25,00k | 575,05k | Derivative Exercise and Sale | 6,11 - 29,70 | 547,34k | - |
| 2025-09-04 | Ms. Jennifer FitzpatrickChief Legal Officer | -10,25k | 174,35k | Derivative Exercise and Sale | 6,11 - 23,12 | - | - |
| 2025-08-29 | Ms. Elena H. RidloffCFO | -9,58k | 240,44k | Automatic Disposition | 25,08 - 25,18 | 38,53k | -19,92% |
| 2025-08-26 | Ms. Elena H. RidloffCFO | -23,42k | 601,86k | Automatic Disposition | 25,10 - 25,97 | 48,12k | -32,73% |
| 2025-08-26 | Mr. Michael CloonanPresident, CEO & Director | -25,00k | 471,61k | Derivative Exercise and Sale | 6,11 - 25,01 | 547,34k | - |
| 2025-08-20 | Mr. Michael CloonanPresident, CEO & Director | -25,00k | 416,00k | Derivative Exercise and Sale | 6,11 - 22,75 | 547,34k | - |
| 2025-08-19 | Ms. Elena H. RidloffCFO | -52,00k | 1,12M | Automatic Disposition | 21,08 - 22,69 | 71,53k | -42,09% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
